At Chemring, Palliser wants a strategic review that could separate or sell Roke, the electronic-warfare business, while accelerating investment in energetic materials. Its Wednesday letter reports an economic interest equivalent to about three percent. Palliser argues that the businesses compete for capital and management attention despite having different needs. That is the shareholder's case; Chemring hasn't agreed to dispose of Roke.

Chemring had announced a disposal plan six days earlier, but for a different business: US Sensors. Management's November twelfth update retained both Roke and Countermeasures and Energetics as its focus. Roke's year was below expectations because UK Ministry of Defence and international orders were delayed, even while order intake reached a record. Selling US Sensors already narrows the group; Palliser is asking it to narrow further.

Roke also has a five-year miniature-radar-altimeter agreement with a US prime contractor, expected to be worth at least a hundred and seventy million dollars, including an initial sixteen-million-dollar production order. The expected agreement value is much larger than that first order. It gives the business a prospective production stream alongside the delayed awards, without making all five years of expected value current revenue.

Energetics requires patience of a different kind. Chemring expects its existing Scottish and Norwegian expansion projects to enter production in twenty twenty-seven and twenty twenty-eight. Its UK business has an initial twenty-three-million-pound, three-year production contract under a longer Ministry of Defence framework. Those projects put actual dates and orders behind the capital-allocation debate. They were company plans before Palliser's letter, not concessions made in response to it.

Source 1 · Source 2 · Source 3 · Source 4